Inovio Pharmaceuticals Inc (INO)

[erdos47]

When the infection rate was going down in the US, there was a concern that vaccine could not be tested effectively in phase 3. The phase 1 going on in S. Korea could show safety and reaction in blood tests, but with their low infection rate, that country would not be useful for ph. 3. Now that, unfortunately, the infection rate is spiking in US, it seems that it would be easier to get volunteers and results of ph. 3 that depend on comparing infections in placebo to treatment groups will give results more quickly. So, I expect that if phase 2/3 was announced on Monday, the process could catch up to the other vaccine trials. The benefit of DNA vaccine is so great, I can't imagine it would be overlooked if shown to be effective, regardless of political pressure to favor the other companies.